Effects of Protein Hydrolysate Supplementation Influencing Strength Recovery and Expression of Muscle Damage Markers Post-exercise

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-08-06

Study Completion Date

2022-04-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A randomised placebo controlled, double-blind, 30 Volunteer trial of Elio™ administered 2.4 grams per day in assessing its effects on post-exercise strength recovery and increases in markers associated with muscle injury and exertion.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Protein Hydrolysate Supplement on Systemic Muscle Function Markers Following Resistance Type Exercise in Male Subjects

NCT05367648

Muscle Injury

COMPLETED NA

The Effect of a Protein Hydrolysate on Muscle Strength Recovery

NCT03063346

Muscle Strength Recovery

COMPLETED NA

Effects of a Recovery Supplement on Body Composition, Performance, Muscular Properties, and Wellbeing

NCT05769101

Protein Deficiency Training Group, Sensitivity Fatigue +2 more

COMPLETED NA

Effects of a Multi-Ingredient Pre-Workout Supplement on Body Composition, Performance, Muscular Properties, and Wellbeing in Adults.

NCT05769088

Protein Deficiency Training Group, Sensitivity Fatigue +2 more

UNKNOWN NA

Effectiveness of Two Different Forms of Marine Oil on Indirect Markers of Muscle Damage and Soreness in Untrained Men

NCT03760757

Inflammation; Muscle

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Periods of intense physical activity and exertion can lead to disruption of normal muscle homeostasis and the resultant muscle injury and recovery can impact upon quality of life especially in adult populations. Recovery post-exercise is therefore important to all active people.

There is a link between high-intensity exercise and reduced power and performance in the following exercise sessions. The effect on performance is measures as a reduced muscle force production or loss in strength and can correlate with delayed onset muscle soreness (DOMS). The reduced power/performance seen 24 hours - 7days post-exercise is affected by recovery methods applied, individual fitness levels and intensity of exercise injury.

Several theories have been proposed to explain the mechanisms underlying DOMS. These include inflammation and muscle damage.

Exercise-induced muscle damage is a transient phenomenon caused by unfamiliar, damaging exercise and is characterized by structural damage to myofibers and secondary inflammation. Signs and symptoms often persist for several days after exercise and typically include muscle soreness, elevated blood levels of intramuscular enzymes such as creatine kinase (CK), lactate dehydrogenase (LDH) and myoglobin (MB) that often result in elevations in circulating markers of inflammation such as C-reactive protein (CRP) and various interleukins. To date, extensive research has been published that explore the many recovery strategies purported to minimize indirect markers of muscle damage.

However, from a nutritional standpoint the results are weak. It is therefore important to develop nutritional products that can lessen the impact of these injuries' individuals succumb to or expedite their recovery.

Nutritional recovery strategies purported to minimise indirect markers of muscle damage and improve the inflammatory response can positively influence the recovery process after damaging exercise.

These strategies could in turn be used to prime the muscle for physical challenges.

Furthermore, there is a clear absence of natural approaches with proven evidence to address DOMS and the resulting performance declines.

Therapies such as non-steroidal anti-inflammatory drugs (NSAIDs) can be taken in the short term to reduce DOMS associated pain and inflammation. However, these drugs do not address performance strength loss linked to DOMS.

Acute injuries to discrete muscle groups can be indirectly detected by an array of systemic biomarkers, which become elevated at various time-points following the event.

This array of biomarkers represents key biochemical processes in muscle homeostasis, cellular integrity, mitochondrial function and inflammation.

Preliminary investigations in vitro and in vivo suggest that the administration of peptides isolated from the protein extract of fava beans, which constitute Elio™, can augment muscle protein synthesis (i.e. phospo-S6) and attenuate proteolytic signaling (i.e. Fbxo32 and Trim63) and surrogate inflammatory markers (TNFα and IL6). Thus, supporting the use of this hydrolysate in maintaining muscle homeostasis and function.

With the present study the investigators will investigate whether daily dietary supplementation of Elio™, over the course of 15 days can prime the muscle by improving strength recovery and attenuating the expression of systemic markers associated with muscle injury and over exertion following resistance type exercise in a healthy male population.

Objectives

To determine the effect of Elio™ supplementation, a protein hydrolysate derived from fava bean protein extract, on strength recovery and markers of muscle health, injury and function following strenuous resistance type exercise in male volunteers, aged between 30 and 45 years old following 17 days of supplementation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Muscle Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Elio (supplement under investigation)

2.4g of Elio administered orally daily with the first meal of the day for a 17 day period

Group Type EXPERIMENTAL

Elio

Intervention Type DIETARY_SUPPLEMENT

Elio™ supplementation, a protein hydrolysate derived from fava bean protein extract

Placebo

2.4g of SMCC administered orally daily with the first meal of the day for a 17 day period

Group Type PLACEBO_COMPARATOR

SMCC

Intervention Type OTHER

Placebo comparator

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Elio

Elio™ supplementation, a protein hydrolysate derived from fava bean protein extract

Intervention Type DIETARY_SUPPLEMENT

SMCC

Placebo comparator

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Males between 30 and 45 years of age
2. Participants agree to comply with study procedures. Participants agree to comply with study procedures.
3. Participants agree to abstain from taking additional supplements throughout the testing period, with particular emphasis placed upon protein-based products
4. Participants agree to maintain their normal diet and exercise routine throughout the study
5. BMI between 18.5 to 29.9 kg/m2
6. Participants agree to refrain from consuming alcohol in the 48 hrs leading up to a test day.
7. Willingness to complete questionnaires, records and diaries associated with the study and to complete all clinic visits.
8. Provide voluntary, written, informed consent to participate in the study.
9. Refrain from any sort of exhaustive physical exercise from 48 hrs prior to each test or blood draw
10. Healthy as determined by medical examination at screening visit
11. Willingness to complete food diaries during the study
12. Must have a smart phone to use the Nutritics App
13. Non-smoker

Exclusion Criteria

1. Alcohol or drug abuse in past year
2. Participation in any other clinical trial in the last 3 months from time of randomisation
3. Volunteer has a known allergy to the test material's active or inactive ingredients
4. Volunteers with unstable medical conditions
5. Any complaints that could interfere with ability to exercise
6. Individuals who are cognitively impaired and/or who are unable to give informed consent
7. Any co-morbidities interacting with mobility or muscle metabolism of the lower limbs (e.g., arthritis, spasticity/rigidity, all neurological disorders and paralysis)
8. Creatine supplements, anticoagulants, corticosteroids, growth hormones,

testosterone, immunosuppressants, or exogenous insulin over the previous three months
9. Presence or history of neurological disorders or significant psychiatric illness.
10. Any other condition which in the Investigator's opinion may adversely affect the volunteer's ability to complete the study or its measures or which may pose significant risk to the volunteer
11. Participation in resistance or aerobic exercise within 48 hours of the test days
12. Participation in \> 3 High-intensity Exercise sessions per Week
13. Undertake no recovery methods such as sea swims, foam rolling, cryotherapy or undue stretching during Days 14-17.
14. Have been in contact with a suspected or confirmed case of Covid-19 in the previous 14 days
15. Are Hepatitis A or B positive, HIV positive or have had a sexual partner who is infected with hepatitis or HIV

Minimum Eligible Age

30 Years

Maximum Eligible Age

45 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes